knowledge -WSS

knowledge

author：focus 2025-10-02 19:15:46 - browse：6791

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： HHS leader on health, climate change and biopharma emissions

WSS

Oprah kicked off a national conversation on obesity. Let's have it

Patient advocates debate FDA's accelerated approval process

The EU Joint Clinical Assessment needs to live up to its promise

There's no autism epidemic. It's an autism diagnosis epidemic

Food as medicine: Medically tailored meals may get standardized

Solve the antibiotic resistance crisis with preventive drugs

Wikipedia

knowledge

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

HHS leader on health, climate change and biopharma emissions

Drug repurposing or repositioning? The language matters

The explosion of genetic testing requires a new approach

Psychedelics group wrestles with new pharma identity

NIH confirmation hearing shows politicization of research

Psychedelics group wrestles with new pharma identity

Covid vaccine financial winners and losers, from Pfizer to Novavax

In Memoriam: Notable people who died in 2023

Studies point to risks of excluding people with obesity from drug trials

leisure time

CEOs share strategies for surviving biotech slump

Hospital price transparency does save money, advocate argues

FDA gives detailed accounting of AI

STAT Readout Newsletter: Today's biggest biotech updates

CEOs share strategies for surviving biotech slump

Abortion pill case raises question: who can sue the FDA?

focus

Wikipedia

focus

explore